Clinical Trial Update: Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety of BBC1501 given as an intravitreal injection in patients with neovascular age-related macular degeneration; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• BBC1501

Snippet

Sponsor: Benobio Co., Ltd. | Conditions: Age-Related Macular Degeneration | Phase 1 | Status: RECRUITING